Vanita R Aroda

Summary

Country: USA

Publications

  1. doi request reprint Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review
    Vanita R Aroda
    Department of Endocrinology, Diabetes, and Metabolism, MedStar Health Research Institute, Hyattsville, MD 20782, USA
    Clin Ther 34:1247-1258.e22. 2012
  2. pmc Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes
    Vanita R Aroda
    MedStar Health Research Institute, Hyattsville, Maryland 20782, USA
    Diabetes Technol Ther 15:117-23. 2013
  3. pmc Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial
    Vanita R Aroda
    Veterans Affairs San Diego Healthcare System, San Diego, California, USA
    J Clin Endocrinol Metab 94:469-76. 2009
  4. doi request reprint The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review
    Vanita R Aroda
    Endocrinology, Diabetes, and Metabolism, MedStar Health Research Institute, Washington, DC 20003, USA
    Diabetes Metab Res Rev 27:528-42. 2011
  5. doi request reprint Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetes
    Vanita R Aroda
    Endocrinology, Diabetes, and Metabolism, MedStar Health Research Institute, Hyattsville, MD 20782, USA
    Postgrad Med 123:228-38. 2011
  6. doi request reprint Approach to the patient with prediabetes
    Vanita R Aroda
    Med Star Clinical Research Center, 650 Pennsylvania Avenue SE, Washington, DC 20003, USA
    J Clin Endocrinol Metab 93:3259-65. 2008

Detail Information

Publications6

  1. doi request reprint Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review
    Vanita R Aroda
    Department of Endocrinology, Diabetes, and Metabolism, MedStar Health Research Institute, Hyattsville, MD 20782, USA
    Clin Ther 34:1247-1258.e22. 2012
    ..Considerable clinical data on the treatment of type 2 diabetes with incretin-based therapies (glucagon-like peptide 1 receptor agonists [GLP-1RAs] and dipeptidyl-peptidase IV [DPP-4] inhibitors) are available...
  2. pmc Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes
    Vanita R Aroda
    MedStar Health Research Institute, Hyattsville, Maryland 20782, USA
    Diabetes Technol Ther 15:117-23. 2013
    ..This study evaluated the relationship between skin intrinsic fluorescence (SIF) and long-term mean hemoglobin A1c (HbA1c) in individuals with type 1 diabetes...
  3. pmc Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial
    Vanita R Aroda
    Veterans Affairs San Diego Healthcare System, San Diego, California, USA
    J Clin Endocrinol Metab 94:469-76. 2009
    ..Polycystic ovary syndrome (PCOS) is characterized by insulin resistance, compensatory hyperinsulinemia, increased prevalence of impaired glucose tolerance, and increased ovarian androgen biosynthesis...
  4. doi request reprint The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review
    Vanita R Aroda
    Endocrinology, Diabetes, and Metabolism, MedStar Health Research Institute, Washington, DC 20003, USA
    Diabetes Metab Res Rev 27:528-42. 2011
    ..Primary tolerability issues include transient gastrointestinal symptoms, common with GLP-1 receptor agonists, which can be reduced through dose titration...
  5. doi request reprint Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetes
    Vanita R Aroda
    Endocrinology, Diabetes, and Metabolism, MedStar Health Research Institute, Hyattsville, MD 20782, USA
    Postgrad Med 123:228-38. 2011
    ..This review describes the similarities and differences between exenatide delivered as a twice-daily or as a once-weekly injection to provide a better understanding of the clinical effects and potential clinical uses of each...
  6. doi request reprint Approach to the patient with prediabetes
    Vanita R Aroda
    Med Star Clinical Research Center, 650 Pennsylvania Avenue SE, Washington, DC 20003, USA
    J Clin Endocrinol Metab 93:3259-65. 2008
    ..This article will review some of the issues surrounding the identification and treatment of prediabetes, with an interpretation of the available data to help guide management...